Abbott creates and employs breakthrough science to improve people’s health. Today, there are more than 100,000 of them around the world dedicated to helping people live fuller lives in greater health and dignity.
Abbott are always looking to the future, anticipating changes in medical science and technology. Putting customers at the center of everything they do, Abbott build their portfolio strategically for relevance to where medicine and technology, their markets, customers and society are heading.
Biosense Webster, Inc., have one goal — to ensure those with cardiac arrhythmias can live the lives they want. This means transforming the latest advancements in electrophysiology into a suite of tools that empowers physicians with a range of treatments for the best outcomes. Quality products and approaches are achievable only through collaboration with the smartest minds in electrophysiology. For more than 30 years, Biosense Webster have been the global market leader in the science and technology of cardiac arrhythmia treatment, working with thousands of electrophysiologists to identify and develop diagnostic and treatment tools. And through onsite training, online courses and their global education centers, they work together to set new standards every day.
EBR Systems is the developer of the world’s smallest, leadless cardiac pacing device, overcoming the challenges associated with traditional lead based pacemakers. The WiSE CRT System is used in conjunction with another implanted pacemaker to provide cardiac resynchronisation therapy (CRT) to patients who are unable to receive CRT from both traditional lead-based systems and leadless intracardiac pacemakers, or those at high risk of complications from an upgrade procedure.
Dot Medical was founded in 1997 by Ian Rankin and now has an established reputation in the Medical Device Industry, particularly in the field of Cardiology, Respiration and Airway Management and Cardiac Surgery. Dot Medical has over 300 products in its total portfolio, including OSYPKA, the Zoll Lifevest Wearable Defibrillator and Bardy p-wave centric ECG monitoring patch.
AtriCure provides innovative technologies for the treatment of AF and related conditions. The Convergent Approach is a minimally invasive, cardiac ablation that combines the expertise of cardiac surgeons and electrophysiologists For more information, visit AtriCure.com or follow us on Twitter @AtriCure.